Opendata, web and dolomites

PARK-IT

Unobtrusive, continuous and quantitative assessment of Parkinson’s disease: hard evidence for optimal disease management with information technologies

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "PARK-IT" data sheet

The following table provides information about the project.

Coordinator
SENSE4CARE SL 

Organization address
address: CALLE JORDI GIRONA 1-3 EDIFICIO K2M PARC UPC
city: BARCELONA
postcode: 8034
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.sense4care.com/en/about-us/parkinson
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-06-01   to  2015-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SENSE4CARE SL ES (BARCELONA) coordinator 50˙000.00

Map

 Project objective

Sense4Care S.L. (S4C) is high-tech SME constituted in Barcelona in 2013 as a spin-off of the Universitat Politècnica de Catalunya - BarcelonaTech (UPC) with a clear objective: taking to the market the results of several research projects. UPC itself holds 5% of the shares of the company, and the rest belongs to professors, researchers and investors. UPC was the Coordinator and main beneficiary of the FP7-ICT project called REMPARK1 project, and has legally transferred the exploitation rights of the project results to S4C, with the aim of commercialising a product that can dramatically improve the lives of Parkinson’s Disease (PD) sufferers.

The main result from the FP7-REMPARK project is the kinetic monitor PARK-IT, which can be exploited as a standalone product. PARK-IT is a new gold-standard, continuous and quantitative monitoring medical device for assessing the status of Parkinson Disease patients. PARK-IT device, based in movement detection and complex algorithms, allows the doctors to precisely adjust the medication of PD patients, overcoming one of the main problems that PD patients face. It constitutes a disruptive innovation answering to an unmet need.

The present innovation business project is therefore focused in taking this device to the market through a clear and innovative business model.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PARK-IT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PARK-IT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

Starcounter (2017)

In-Memory Computing and Artificial Intelligence Platform for Building Next Generation Enterprise Software

Read More  

scanvid (2017)

ScanVid - One-Click Integrated Access to Product-related Digital Content

Read More  

BioAhead (2017)

BioAhead – an innovative optimization algorithm for amino acid chain analytics

Read More